Hygea Medical Technology Co., Ltd, a China-based medical device company, has announced that its subsidiary, Beijing Ailin Medical Technology Co., Ltd, has received marketing approval in China for an innovative intrahepatic puncture instrument designed for use via the jugular vein. The instrument is intended for intrahepatic portal vein puncture to facilitate portal vein shunting surgery, aiming to reduce portal vein pressure.
This novel product integrates a metal needle with flexibility that is easy to puncture and resistant to deformation. It introduces, for the first time, variable diameter technology which enhances the overall puncture performance and minimizes puncture-related trauma. Additionally, it features the first application of hydrophilic coating technology in transjugular puncture instruments, which reduces resistance during the push and enhances the product’s performance. The product is designed to enhance surgical efficiency, reduce complications, and improve procedural safety.- Flcube.com
